AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DAPAGLIFLOZIN
106 registrations across 8 African markets— 97 active
Markets with DAPAGLIFLOZIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| DAPAONE 10 Film Coated Tablets | 🇷🇼Rwanda | — | active | May 2031 |
| NONE TABLET, COATED; ORAL | 🇿🇼Zimbabwe | PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD | active | Apr 2031 |
| Diagliz 10 Tablet (Each tablet contains Dapagliflozin 10mg) | 🇬🇭Ghana | — | active | Apr 2031 |
| Diagliz 5 Tablet (Each tablet contains Dapagliflozin 5mg) | 🇬🇭Ghana | — | active | Apr 2031 |
| Diagliz 5 Tablet (Each tablet contains Dapagliflozin 5mg) | 🇬🇭Ghana | — | active | Apr 2031 |
| Diagliz 10 Tablet (Each tablet contains Dapagliflozin 10mg) | 🇬🇭Ghana | — | active | Apr 2031 |
| GLYDA 5 (Dapagliflozin Tablets 5mg) Tablet | 🇰🇪Kenya | Hetero Labs Limited | active | Jan 2031 |
| GLYDA 10 (Dapagliflozin Tablets 10mg) Tablet | 🇰🇪Kenya | Hetero Labs Limited | active | Jan 2031 |
| DAPAGOOD 10 Tablet | 🇰🇪Kenya | ZAIN PHARMA LIMITED | active | Jul 2030 |
| DAPAONE 5 Tablet | 🇰🇪Kenya | MSN LABORATORIES PRIVATE LIMITED.. | active | Jul 2030 |
| SKY PHARM DAPA 5MG TABLET, COATED; ORAL | 🇿🇼Zimbabwe | ADVENTURA INVESTMENTS LTD | active | May 2030 |
| FORXIGA 5MG TABLET | 🇬🇭Ghana | — | active | May 2030 |
| FORXIGA 5MG TABLET | 🇬🇭Ghana | — | active | May 2030 |
| FORXIGA 10MG TABLETS | 🇬🇭Ghana | — | active | May 2030 |
| FORXIGA 10MG TABLETS | 🇬🇭Ghana | — | active | May 2030 |
| DAPAGLIFLOZIN 10 mg ADCO | 🇿🇦South Africa | Adcock Ingram Limited | active | Mar 2030 |
| DAPAGLIFLOZIN 5 mg ADCO | 🇿🇦South Africa | Adcock Ingram Limited | active | Mar 2030 |
| DAPAGLIFLOZIN 10 COSPHARM TABLET, COATED; ORAL | 🇿🇼Zimbabwe | COSPHARM INVESTMESTS PVT LTD | active | Feb 2030 |
| DAPAGLIFLOZIN 5 COSPHARM TABLET, COATED; ORAL | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS PVT LTD | active | Feb 2030 |
| GLYDA 5 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Jan 2030 |
| GLYDA 10 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Jan 2030 |
| SKY PHARMA DAPA 10MG TABLET, COATED; ORAL | 🇿🇼Zimbabwe | ADVENTURA INVESTMENTS LTD | active | Jan 2030 |
| ALCAN TABLETS (Each film coated tablet contains Dapagliflozin 10mg) | 🇬🇭Ghana | — | active | Dec 2029 |
| ALCAN TABLETS (Each film coated tablet contains Dapagliflozin 5mg) | 🇬🇭Ghana | — | active | Dec 2029 |
| ALCAN TABLETS (Each film coated tablet contains Dapagliflozin 5mg) | 🇬🇭Ghana | — | active | Dec 2029 |
| ALCAN TABLETS (Each film coated tablet contains Dapagliflozin 10mg) | 🇬🇭Ghana | — | active | Dec 2029 |
| REDIFARG 10 | 🇿🇦South Africa | Dr ReddyÆs Laboratories (Pty) Ltd | active | Sept 2029 |
| REDIFARG 5 | 🇿🇦South Africa | Dr ReddyÆs Laboratories (Pty) Ltd | active | Sept 2029 |
| DAPAGLIFLOZIN 5 mg ASCEND | 🇿🇦South Africa | Ascend Laboratories (Pty) Ltd | active | Jul 2029 |
| DAPAGLIFLOZIN 10 mg ASCEND | 🇿🇦South Africa | Ascend Laboratories (Pty) Ltd | active | Jul 2029 |
| DEXIGLOFOZIN TABLET, COATED; ORAL | 🇿🇼Zimbabwe | ZETA PHARMA FOR PHARMACEUTICAL INDUSTRIES | active | Jul 2029 |
| GLUDAPZIN 10 | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | Jul 2029 |
| GLUDAPZIN 5 | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | Jul 2029 |
| AVAXIGA 10 | 🇿🇦South Africa | Innovata Pharmaceuticals | active | Jul 2029 |
| AVAXIGA 5 | 🇿🇦South Africa | Innovata Pharmaceuticals | active | Jul 2029 |
| DAPAONE 10 Tablet | 🇰🇪Kenya | MSN LABORATORIES PRIVATE LIMITED.. | active | Mar 2029 |
| DEPAGLOZ 5 | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Feb 2029 |
| DEPAFLIN 5 | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Feb 2029 |
| DEPAFLIN 10 | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Feb 2029 |
| DAPAGLIFLOZIN 5 mg HETERO | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Feb 2029 |
| DAPAGLIFLOZIN 10 mg HETERO | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Feb 2029 |
| DEPAGLOZ 10 | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Feb 2029 |
| DAPAGLIFLOZIN 10 UNICORN | 🇿🇦South Africa | Unicorn Pharmaceuticals (Pty) Ltd | active | Feb 2029 |
| DAPAGLIFLOZIN 5 UNICORN | 🇿🇦South Africa | Unicorn Pharmaceuticals (Pty) Ltd | active | Feb 2029 |
| DAPIFLO 10 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Dec 2028 |
| FARFLOZIN 10 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Dec 2028 |
| DAPIFLO 5 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Dec 2028 |
| FARFLOZIN 5 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Dec 2028 |
| LIFLOZ 5 | 🇿🇦South Africa | Abbott Laboratories S.A. (Pty) Ltd | active | Sept 2028 |
| LIFLOZ 10 | 🇿🇦South Africa | Abbott Laboratories S.A. (Pty) Ltd | active | Sept 2028 |
Showing 50 of 106 registrations. Sign up free to search and export all.
DAPAGLIFLOZIN in Africa — Regulatory Overview
DAPAGLIFLOZIN is registered across 8 African markets with 106 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Ghana, Uganda, Tanzania and 4 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 106 registrations, 97 (92%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.